Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Fractional CO2 Laser for the Treatment of Vulvovaginal Atrophy: a Double-blinded Randomized Placebo-controlled Clinical Trial.

NCT04021966 is registered in ClinicalTrials.gov with prof. dr. Jan Deprest as lead sponsor.

NCT NCT04021966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04021966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Fractional CO2 Laser for the Treatment of Vulvovaginal Atrophy: a Double-blinded Randomized Placebo-controlled Clinical Trial.
Lead sponsor
prof. dr. Jan Deprest
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2019
Completion date
December 31, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal atrophy